Cited by 305Cardiovascular Syncope and Autonomic DisordersHeart Rate Variability and Autonomic ControlLong-Term Effects of COVID-19

The DOI matches its Crossref record; 115 of the 124 references it cites were found in a registry or an index; 1 of the 59 sources its claims cite were checked for support.

Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1

Open access

Abstract

Postural orthostatic tachycardia syndrome (POTS) is a chronic and often disabling disorder characterized by orthostatic intolerance with excessive heart rate increase without hypotension during upright posture. Patients often experience a constellation of other typical symptoms including fatigue, exercise intolerance and gastrointestinal distress. A typical patient with POTS is a female of child-bearing age, who often first displays symptoms in adolescence. The onset of POTS may be precipitated by immunological stressors such as a viral infection. A variety of pathophysiologies are involved in the abnormal postural tachycardia response; however, the pathophysiology of the syndrome is incompletely understood and undoubtedly multifaceted. Clinicians and researchers focused on POTS convened at the National Institutes of Health in July 2019 to discuss the current state of understanding of the pathophysiology of POTS and to identify priorities for POTS research. This article, the first of two articles summarizing the information discussed at this meeting, summarizes the current understanding of this disorder and best practices for clinical care. The evaluation of a patient with suspected POTS should seek to establish the diagnosis, identify co-morbid conditions, and exclude conditions that could cause or mimic the syndrome. Once diagnosed, management typically begins with patient education and non-pharmacologic treatment options. Various medications are often used to address specific symptoms, but there are currently no FDA-approved medications for the treatment of POTS, and evidence for many of the medications used to treat POTS is not robust.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.autneu.2021.102828

Cites

115 of 115 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

30 Not checked yet · 10 No basis given · 9 Own interpretation · 1 Supported

Verify all 58 references — free account
  • It may state two separate claims as one. 22
  • Probably not a substantial claim. 13
29 of 29
  • The paper relies on this without support.

    POTS is common.

    “Postural orthostatic tachycardia syndrome (POTS) is common but the exact prevalence has not been determined”
  • The paper relies on this without support.

    Misdiagnosis of POTS is common.

    “Although there is a consensus clinical definition for POTS, misdiagosis is common.”
  • The paper relies on this without support.

    Clinical evaluation and treatment approaches for POTS are not standardized.

    “The clinical evaluation of patients with suspected POTS is not standardized, nor are treatment approaches.”
  • The paper relies on this without support.

    There is a lack of familiarity with POTS in the medical community.

    “There is a lack of familiarity with POTS in the medical community”
  • The paper relies on this without support.

    A majority of POTS patients report chronic symptoms with recurrent exacerbations.

    “Significant symptomatic recovery has been reported by a subset of patients, but a majority report chronic symptoms with recurrent exacerbations.”
  • The paper relies on this without support.

    No FDA-approved medications exist for the treatment of POTS.

    “there are currently no FDA-approved medications for the treatment of POTS”
6 of 6

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 124 references

Research works printed but not linked: 1

  1. Orban, 2020, Immunogenetic risk markers in postural orthostatic tachycardia syndrome [abstract]. Clin. Auton, Res, 30, 492

Cited by

Sorted by citations

See all 305

Metadata

Authors
Vernino, S., Bourne, K. M., Stiles, L. E., Grubb, B. P., Fedorowski, A., Stewart, J. M., Arnold, A. C., Pace, L. A., Axelsson, J., Boris, J. R., Moak, J. P., Goodman, B. P., Chémali, K. R., Chung, T. H., Goldstein, D. S., Diedrich, A., Miglis, M. G., Cortez, M. M., Miller, A. J., Freeman, R., Biaggioni, I., Rowe, P. C., Sheldon, R. S., Shibao, C. A., Systrom, D. M., Cook, G. A., Doherty, T. A., Abdallah, H. I., Darbari, A., & Raj, S. R.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • University of Calgary (CA)
  • Stony Brook University (US)
  • University of Toledo Medical Center (US)
  • Lund University (SE)
  • New York Medical College (US)
  • Pennsylvania State University (US)
  • University of Utah (US)
  • Karolinska University Hospital (SE)
  • George Washington University (US)
  • Mayo Clinic (US)
  • Eastern Virginia Medical School (US)
  • Johns Hopkins University (US)
  • National Institutes of Health (US)
  • Stanford Medicine (US)
  • Beth Israel Deaconess Medical Center (US)
  • Vanderbilt University Medical Center (US)
  • Brigham and Women's Hospital (US)
  • Uniformed Services University of the Health Sciences (US)
  • University of California San Diego (US)
  • Children's National (US)
Corresponding author
Raj, Satish R.
Venue
Autonomic Neuroscience
Publisher
Elsevier BV
Published
2021-11
Volume
235
Pages
102828
ISSN
1566-0702 (ISSN-L)
OpenAlex
W3170339939
Cited by
304
References
124
Citations by year
2026: 59 · 2025: 77 · 2024: 75 · 2023: 46 · 2022: 44 · 2021: 2
FWCI
39.18
Type
journal article
Language
en
Open access
Locations
  • Autonomic Neuroscience (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Touro Scholar (Touro College) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
Keywords
postural orthostatic tachycardia syndrome, orthostatic intolerance, pathophysiology, diagnosis, non-pharmacological treatment, pharmacotherapy, autonomic dysfunction, fatigue, exercise intolerance, gastrointestinal symptoms
MeSH terms
Adolescent, Female, Heart Rate, Humans, National Institutes of Health (U.S.), United States, Consensus, Orthostatic Intolerance, Postural Orthostatic Tachycardia Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review